Taiwan FDA registration 2be16c08898306828f45038efe68ecf2

Platinum Dual Function Test System (Uric Acid/Total Cholesterol) (Unsterilized)

TW: 百捷優善雙功能檢驗系統(尿酸/總膽固醇)(未滅菌)

Taiwan·Risk Class 1·Qinli Biotechnology Co., Ltd. New North Plant·Registered Feb 15, 2023 – Feb 15, 2028Active

Registration details

Analysis ID: 2be16c08898306828f45038efe68ecf2

Company information

Manufacturer: Qinli Biotechnology Co., Ltd. New North Plant
Manufacturer Country: Taiwan, Province of China
Authorized Representative: GENERAL LIFE BIOTECHNOLOGY CO., LTD.

Product details

Intended Use: Limited to the classification and grading management of medical equipment, "cholesterol (total) test system (A.1175)", "uric acid test system (A.1775)" the first level identification range.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1775 Uric acid testing system;; A.1175 Cholesterol (Total) Testing System
Import Information: 國產;; QMS/QSD

Dates and status

Registration Date: Feb 15, 2023
Expiry Date: Feb 15, 2028

About this record

Access comprehensive regulatory information for Platinum Dual Function Test System (Uric Acid/Total Cholesterol) (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 2be16c08898306828f45038efe68ecf2 and manufactured by Qinli Biotechnology Co., Ltd. New North Plant. The authorized representative in Taiwan is GENERAL LIFE BIOTECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.